🇺🇸 Zoledronic acid IV in United States

12 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Ankle Fracture — 2 reports (16.67%)
  2. Deep Vein Thrombosis — 2 reports (16.67%)
  3. Arthralgia — 1 report (8.33%)
  4. Body Temperature Increased — 1 report (8.33%)
  5. Bone Pain — 1 report (8.33%)
  6. Bursitis — 1 report (8.33%)
  7. Cardiac Failure — 1 report (8.33%)
  8. Cellulitis — 1 report (8.33%)
  9. Comminuted Fracture — 1 report (8.33%)
  10. Decreased Appetite — 1 report (8.33%)

Source database →

Zoledronic acid IV in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Zoledronic acid IV approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Zoledronic acid IV in United States?

National Taiwan University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.